BRK-B vs INV
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
The company exhibits severe financial distress, highlighted by a Piotroski F-Score of 1/9, indicating critical weakness in fundamental health. While revenue growth is robust at 80.30%, the valuation is disconnected from reality with a Price/Sales ratio of 169.02 and a catastrophic operating margin of -3859.12%. Despite a 'strong_buy' analyst consensus from a very small sample, heavy insider selling of $10.16M and a bearish technical trend suggest a high-risk speculative environment.
Compare Another Pair
Related Comparisons
BRK-B vs INV: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Innventure, Inc. (INV) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.